IONQ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Considering the user's beginner investment knowledge, long-term strategy, and available capital, IONQ is not a strong buy at the moment. While the company has shown significant revenue growth and is positioned in a promising quantum computing market, the financial performance shows substantial losses, and there are mixed analyst ratings. Additionally, technical indicators and trading signals do not suggest a strong entry point currently.
The MACD is positive at 0.919, indicating bullish momentum, but it is contracting. RSI is neutral at 49.035, showing no clear trend. Moving averages are converging, and the stock is trading near its pivot point of 35.879. Key support is at 31.398, and resistance is at 40.36. Overall, the technical indicators suggest a neutral trend.
IonQ's revenue grew by 429% YoY in Q4 2025, reflecting strong market demand.
The company has become a vertically integrated full-stack quantum platform, which could enhance its competitive position.
The quantum computing market is projected to grow significantly, offering long-term growth potential.
Net income dropped by -473.11% YoY, and gross margin fell significantly to -36.11%.
Analysts have lowered price targets, citing concerns about commercialization and limited applied research in the quantum computing space.
Wolfpack Research's short report raises concerns about lost Pentagon contracts and alleged financial misrepresentation.
In Q4 2025, revenue increased by 428.52% YoY to $61.89 million. However, net income dropped by -473.11% YoY to -$753.67 million, and EPS fell by -334.41% YoY to 2.18. Gross margin also dropped significantly to -36.11%. While revenue growth is strong, profitability metrics are deeply concerning.
Analysts have mixed ratings on IONQ. Benchmark, Jefferies, and Mizuho maintain Buy ratings with reduced price targets, citing strong growth potential. However, DA Davidson and JPMorgan have Neutral ratings, and Morgan Stanley has an Equal Weight rating, reflecting concerns about commercialization and market uncertainty.
